How we mitigate the risks that could affect the quality or safety of a study.
Guidance from the US FDA outlines steps in a risk-based approach to monitoring. Risk-based monitoring is the process of ensuring the quality of clinical trials by identifying, assessing, monitoring and mitigating the risks that could affect the quality or safety of a clinical study.